Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher

Prabhudas Lilladher has come out with its third quarter (October-December’ 21) earnings estimates for the Pharma sector. The brokerage house expects Eris Lifesciences to report net profit at Rs 101.4 crore up 12.4% year-on-year (down 14.4% quarter-on-quarter).

Net Sales are expected to increase by 11.9 percent Y-o-Y (down 3.5 percent Q-o-Q) to Rs 347.2 crore, according to Prabhudas Lilladher.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 12.6 percent Y-o-Y (down 13.7 percent Q-o-Q) to Rs 120.7 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.